| 2012 | 2013 | 2014 | 2015 | 2016 | |
|---|---|---|---|---|---|
| Business | |||||
| Sales€ million | 1,734.9 | 1,830.4 | 2,120.1 | 2,601.7 | 2,903.2 |
| EBITDA1€ million | 338.9 | 373.1 | 464.5 | 572.2 | 625.2 |
| EBITDA margin1in % | 19.5 | 20.4 | 21.9 | 22.0 | 21.5 |
| EBIT1€ million | 252.6 | 283.1 | 337.9 | 395.2 | 423.3 |
| EBIT margin1in % | 14.6 | 15.5 | 15.9 | 15.2 | 14.6 |
| Net income1€ million | 157.5 | 172.3 | 211.6 | 246.8 | 265.9 |
| Balance sheet total (as of December 31)€ million | 2,150.22 | 2,210.4 | 3,999.8 | 4,183.8 | 4,752.8 |
| Capital ratio (as of December 31)in % | 40.92 | 43.0 | 35.8 | 38.0 | 36.4 |
| Investments (without M & A)€ million | 70.3 | 70.7 | 101.3 | 147.2 | 168.4 |
| Net debt (incl. pension provisions and similar obligations) /EBITDA(as of December 31)1ratio | 2.42 | 2.0 | 3.2 | 2.8 | 3.1 |
| Research and development expenses1€ million | 113.8 | 127.0 | 138.9 | 169.6 | 186.0 |
| Operating cash flow€ million | 219.5 | 274.8 | 343.2 | 375.2 | 338.8 |
| Capital Market | |||||
| Shares issued as of balance sheet datemillions | 118.2 | 118.2 | 129.8 | 129.8 | 129.8 |
| Share price at end of fiscal year (Xetra®closing price)in € | 27.12 | 33.50 | 50.13 | 61.33 | 57.83 |
| Market capitalization at end of fiscal year€ million | 3,204.9 | 3,958.8 | 6,507.5 | 7,961.4 | 7,507.1 |
| Earnings per share1in € | 1.33 | 1.46 | 1.69 | 1.90 | 2.05 |
| Dividend per sharein € | 0.65 | 0.70 | 0.75 | 0.80 | 0.853 |
| Environment | |||||
| Carbon dioxide emissions (Scope 1 and Scope 2)4,5in t | 240.51 | 226.00 | 201.76 | 243.04 | 230.05 |
| Chemical oxygen demand (CSB) in wastewater4,5in t | 5.73 | 5.68 | 4.96 | 5.21 | 4.31 |
| Sensitive waste4,5in t | 16.51 | 14.99 | 15.90 | 14.20 | 14.34 |
| Employees | |||||
| Employees (as of December 31)FTE6 | 5,669 | 5,959 | 8,160 | 8,301 | 8,944 |
| Fluctuation ratein % | 5.3 | 4.4 | 4.8 | 5.1 | 4.8 |
| Number of accidentsMAQ7 | 5.3 | 5.3 | 4.8 | 3.9 | 3.8 |
|
|||||